Pharmanutra Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	18.58	15.49	18.93	22.05	29.41
Short-Term Investments	12.04	13.48	6.19	4.81	4.53
Cash & Short-Term Investments	30.62	28.97	25.12	26.86	33.94
Cash Growth	5.67%	15.34%	-6.49%	-20.86%	63.14%
Accounts Receivable	24.76	22.05	19.22	21.65	16.67
Other Receivables	2.43	2.1	2.7	2.12	0.99
Receivables	27.2	24.15	21.92	23.77	17.66
Inventory	8.85	6.94	8.17	5.26	2.87
Prepaid Expenses	2.1	0.68	1.06	0.93	0.15
Other Current Assets	4.14	4.26	2.42	1.9	0.9
Total Current Assets	72.9	65.01	58.68	58.73	55.52
Property, Plant & Equipment	24.13	25.66	26.36	17.06	8.37
Long-Term Investments	0	0	0	0	0.25
Goodwill	17.56	17.56	17.56	17.56	2.75
Other Intangible Assets	3.81	3.71	3.73	3.15	2.45
Long-Term Deferred Tax Assets	2.15	1.4	1.52	1.31	1.24
Long-Term Deferred Charges	0.68	0.67	0.08	-	-
Other Long-Term Assets	3.99	3.39	4.5	2.36	0.77
Total Assets	125.23	117.41	112.44	100.16	71.36
Accounts Payable	17.36	13.5	13.66	14.89	8.49
Accrued Expenses	4.19	3.81	3.23	2.83	2.6
Short-Term Debt	0.6	0.41	0.63	-	-
Current Portion of Long-Term Debt	4.06	4.04	3.59	3.37	0.56
Current Portion of Leases	0.41	0.32	0.37	0.25	0.26
Current Income Taxes Payable	0.89	1.96	2.18	0.98	2.92
Current Unearned Revenue	2.54	2.3	2.45	2	1.26
Other Current Liabilities	0.99	1.02	1.55	1.48	0.66
Total Current Liabilities	31.03	27.34	27.65	25.79	16.75
Long-Term Debt	14.35	18.15	22.19	13.61	5
Long-Term Leases	1.1	1.36	1.24	0.5	0.53
Pension & Post-Retirement Benefits	1.36	1.33	1.21	1.07	2.52
Other Long-Term Liabilities	6.15	7.09	5.75	8.23	1.48
Total Liabilities	53.99	55.27	58.04	49.21	26.27
Common Stock	1.12	1.12	1.12	1.12	1.12
Retained Earnings	20	16.61	12.83	15.27	14
Treasury Stock	-5.9	-4.56	-4.01	-	-
Comprehensive Income & Other	56.01	48.97	44.47	34.55	29.96
Shareholders' Equity	71.24	62.14	54.41	50.95	45.08
Total Liabilities & Equity	125.23	117.41	112.44	100.16	71.36
Total Debt	20.51	24.27	28.02	17.73	6.35
Net Cash (Debt)	10.1	4.7	-2.9	9.14	27.59
Net Cash Growth	114.91%	-	-	-66.89%	44.14%
Net Cash Per Share	1.05	0.49	-0.30	0.94	2.85
Filing Date Shares Outstanding	9.58	9.6	9.61	9.62	9.68
Total Common Shares Outstanding	9.58	9.6	9.61	9.64	9.68
Working Capital	41.87	37.67	31.03	32.94	38.77
Book Value Per Share	7.44	6.47	5.66	5.28	4.66
Tangible Book Value	49.87	40.86	33.11	30.24	39.88
Tangible Book Value Per Share	5.21	4.26	3.44	3.14	4.12
Land	20.74	20.65	20.42	0.75	0.64
Machinery	8.08	7.61	6.86	3.26	2.85
Construction In Progress	0.31	0.16	0.13	14.92	6.14

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.